Exenatide Pregnancy Registry - Type 2 Diabetes in Pregnancy
Phase of Trial: Phase IV
Latest Information Update: 02 Jun 2016
At a glance
- Drugs Exenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors INC Research; Kendle International
- 24 May 2016 Status changed from recruiting to discontinued.
- 04 Aug 2015 Planned number of patients changed from 400 to 200 as reported by ClinicalTrials.gov record.
- 23 Nov 2014 Planned End Date changed from 1 Jan 2016 to 1 Jan 2020 as reported by ClinicalTrials.gov record.